These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12485957)

  • 21. The disposition, metabolism, and pharmacokinetics of a selective metabotropic glutamate receptor agonist in rats and dogs.
    Johnson JT; Mattiuz EL; Chay SH; Herman JL; Wheeler WJ; Kassahun K; Swanson SP; Phillips DL
    Drug Metab Dispos; 2002 Jan; 30(1):27-33. PubMed ID: 11744608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of CYP2C19 genetic polymorphisms on atomoxetine pharmacokinetics.
    Choi CI; Bae JW; Lee YJ; Lee HI; Jang CG; Lee SY
    J Clin Psychopharmacol; 2014 Feb; 34(1):139-42. PubMed ID: 24346747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
    Vickers S; Duncan CA; Slaughter DE; Arison BH; Greber T; Olah TV; Vyas KP
    Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atomoxetine hydrochloride: clinical drug-drug interaction prediction and outcome.
    Sauer JM; Long AJ; Ring B; Gillespie JS; Sanburn NP; DeSante KA; Petullo D; VandenBranden MR; Jensen CB; Wrighton SA; Smith BP; Read HA; Witcher JW
    J Pharmacol Exp Ther; 2004 Feb; 308(2):410-8. PubMed ID: 14610241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of diltiazem in selected animal species and human beings.
    Piepho RW; Bloedow DC; Lacz JP; Runser DJ; Dimmit DC; Browne RK
    Am J Cardiol; 1982 Feb; 49(3):525-8. PubMed ID: 7058762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of remoxipride in different species. Species differences in metabolism.
    Widman M; Nilsson LB; Bryske B; Lundström J
    Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disposition and metabolism of a novel diurea inhibitor of acyl CoA: cholesterol acyltransferase (YM17E) in the rat and dog.
    Uchida T; Nakamura E; Usui T; Imasaki H; Kawakami R; Watanabe T; Higuchi S
    Xenobiotica; 1994 Dec; 24(12):1223-36. PubMed ID: 7771109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative metabolism of 2,4-dichlorophenoxyacetic acid (2,4-D) in rat and dog.
    van Ravenzwaay B; Hardwick TD; Needham D; Pethen S; Lappin GJ
    Xenobiotica; 2003 Aug; 33(8):805-21. PubMed ID: 12936702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
    Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
    Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics and disposition of picumeterol in animals.
    Barrow A; Camp SJ; Dayal S; Jenner WN; Lashmar D; Oxford JM; Palmer E; Scully NL; Curtis GC; Hughes HM
    Xenobiotica; 1995 Sep; 25(9):993-1007. PubMed ID: 8553692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Species differences in the metabolism and disposition of spironolactone.
    Karim A; Kook C; Zitzewitz DJ; Zagarella J; Doherty M; Campion J
    Drug Metab Dispos; 1976; 4(6):547-55. PubMed ID: 11976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of barnidipine hydrochloride, a potent calcium antagonist, in rat and dog.
    Teramura T; Tokunaga T; Matsumoto H; Watanabe T; Higuchi S
    Xenobiotica; 1996 Feb; 26(2):177-87. PubMed ID: 8868001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biotransformation of the antiemetic 5-HT3 antagonist tropisetron in liver and kidney slices of human, rat and dog with a comparison to in vivo.
    Vickers AE; Fischer V; Connors MS; Biggi WA; Heitz F; Baldeck JP; Brendel K
    Eur J Drug Metab Pharmacokinet; 1996; 21(1):43-50. PubMed ID: 8839677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species-differences in disposition and reductive metabolism of methoxymorpholinodoxorubicin (PNU 152243), a new potential anticancer agent.
    Breda M; Benedetti MS; Battaglia R; Castelli MG; Poggesi I; Spinelli R; Hackett AM; Dostert P
    Pharmacol Res; 2000 Feb; 41(2):239-48. PubMed ID: 10623492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism and disposition of the DOT1L inhibitor, pinometostat (EPZ-5676), in rat, dog and human.
    Waters NJ; Smith SA; Olhava EJ; Duncan KW; Burton RD; O'Neill J; Rodrigue ME; Pollock RM; Moyer MP; Chesworth R
    Cancer Chemother Pharmacol; 2016 Jan; 77(1):43-62. PubMed ID: 26645404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs.
    He H; Tran P; Yin H; Smith H; Flood D; Kramp R; Filipeck R; Fischer V; Howard D
    Drug Metab Dispos; 2009 Mar; 37(3):545-54. PubMed ID: 19074976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of amlodipine in the rat and the dog: a species difference.
    Beresford AP; Macrae PV; Stopher DA
    Xenobiotica; 1988 Feb; 18(2):169-82. PubMed ID: 2967592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disposition of LY333531, a selective protein kinase C beta inhibitor, in the Fischer 344 rat and beagle dog.
    Burkey JL; Campanale KM; O'Bannon DD; Cramer JW; Farid NA
    Xenobiotica; 2002 Nov; 32(11):1045-52. PubMed ID: 12487733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.